1l8g
From Proteopedia
(Difference between revisions)
Line 3: | Line 3: | ||
<StructureSection load='1l8g' size='340' side='right'caption='[[1l8g]], [[Resolution|resolution]] 2.50Å' scene=''> | <StructureSection load='1l8g' size='340' side='right'caption='[[1l8g]], [[Resolution|resolution]] 2.50Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[1l8g]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/ | + | <table><tr><td colspan='2'>[[1l8g]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1L8G OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=1L8G FirstGlance]. <br> |
- | </td></tr><tr id=' | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.5Å</td></tr> |
- | <tr id=' | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=DBD:7-(1,1-DIOXO-1H-BENZO[D]ISOTHIAZOL-3-YLOXYMETHYL)-2-(OXALYL-AMINO)-4,7-DIHYDRO-5H-THIENO[2,3-C]PYRAN-3-CARBOXYLIC+ACID'>DBD</scene></td></tr> |
- | + | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=1l8g FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1l8g OCA], [https://pdbe.org/1l8g PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=1l8g RCSB], [https://www.ebi.ac.uk/pdbsum/1l8g PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=1l8g ProSAT]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=1l8g FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1l8g OCA], [https://pdbe.org/1l8g PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=1l8g RCSB], [https://www.ebi.ac.uk/pdbsum/1l8g PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=1l8g ProSAT]</span></td></tr> | ||
</table> | </table> | ||
== Function == | == Function == | ||
- | + | [https://www.uniprot.org/uniprot/PTN1_HUMAN PTN1_HUMAN] Tyrosine-protein phosphatase which acts as a regulator of endoplasmic reticulum unfolded protein response. Mediates dephosphorylation of EIF2AK3/PERK; inactivating the protein kinase activity of EIF2AK3/PERK. May play an important role in CKII- and p60c-src-induced signal transduction cascades. May regulate the EFNA5-EPHA3 signaling pathway which modulates cell reorganization and cell-cell repulsion.<ref>PMID:21135139</ref> <ref>PMID:22169477</ref> | |
== Evolutionary Conservation == | == Evolutionary Conservation == | ||
[[Image:Consurf_key_small.gif|200px|right]] | [[Image:Consurf_key_small.gif|200px|right]] | ||
Line 21: | Line 20: | ||
</jmol>, as determined by [http://consurfdb.tau.ac.il/ ConSurfDB]. You may read the [[Conservation%2C_Evolutionary|explanation]] of the method and the full data available from [http://bental.tau.ac.il/new_ConSurfDB/main_output.php?pdb_ID=1l8g ConSurf]. | </jmol>, as determined by [http://consurfdb.tau.ac.il/ ConSurfDB]. You may read the [[Conservation%2C_Evolutionary|explanation]] of the method and the full data available from [http://bental.tau.ac.il/new_ConSurfDB/main_output.php?pdb_ID=1l8g ConSurf]. | ||
<div style="clear:both"></div> | <div style="clear:both"></div> | ||
- | <div style="background-color:#fffaf0;"> | ||
- | == Publication Abstract from PubMed == | ||
- | Utilizing structure-based design, we have previously demonstrated that it is possible to obtain selective inhibitors of protein-tyrosine phosphatase 1B (PTP1B). A basic nitrogen was introduced into a general PTP inhibitor to form a salt bridge to Asp48 in PTP1B and simultaneously cause repulsion in PTPs containing an asparagine in the equivalent position [Iversen, L. F., et al. (2000) J. Biol. Chem. 275, 10300-10307]. Further, we have recently demonstrated that Gly259 in PTP1B forms the bottom of a gateway that allows easy access to the active site for a broad range of substrates, while bulky residues in the same position in other PTPs cause steric hindrance and reduced substrate recognition capacity [Peters, G. H., et al. (2000) J. Biol. Chem. 275, 18201-18209]. The current study was undertaken to investigate the feasibility of structure-based design, utilizing these differences in accessibility to the active site among various PTPs. We show that a general, low-molecular weight PTP inhibitor can be developed into a highly selective inhibitor for PTP1B and TC-PTP by introducing a substituent, which is designed to address the region around residues 258 and 259. Detailed enzyme kinetic analysis with a set of wild-type and mutant PTPs, X-ray protein crystallography, and molecular modeling studies confirmed that selectivity for PTP1B and TC-PTP was achieved due to steric hindrance imposed by bulky position 259 residues in other PTPs. | ||
- | |||
- | Steric hindrance as a basis for structure-based design of selective inhibitors of protein-tyrosine phosphatases.,Iversen LF, Andersen HS, Moller KB, Olsen OH, Peters GH, Branner S, Mortensen SB, Hansen TK, Lau J, Ge Y, Holsworth DD, Newman MJ, Hundahl Moller NP Biochemistry. 2001 Dec 11;40(49):14812-20. PMID:11732900<ref>PMID:11732900</ref> | ||
- | |||
- | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
- | </div> | ||
- | <div class="pdbe-citations 1l8g" style="background-color:#fffaf0;"></div> | ||
==See Also== | ==See Also== | ||
Line 37: | Line 27: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
- | [[Category: | + | [[Category: Homo sapiens]] |
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
- | + | [[Category: Andersen HS]] | |
- | [[Category: Andersen | + | [[Category: Branner S]] |
- | [[Category: Branner | + | [[Category: Ge Y]] |
- | [[Category: Ge | + | [[Category: Hansen TK]] |
- | [[Category: Hansen | + | [[Category: Holsworth DD]] |
- | [[Category: Holsworth | + | [[Category: Iversen LF]] |
- | [[Category: Iversen | + | [[Category: Lau J]] |
- | [[Category: Lau | + | [[Category: Moller KB]] |
- | [[Category: Moller | + | [[Category: Moller NPH]] |
- | [[Category: Moller | + | [[Category: Mortensen SB]] |
- | [[Category: Mortensen | + | [[Category: Newman MJ]] |
- | [[Category: Newman | + | [[Category: Olsen OH]] |
- | [[Category: Olsen | + | [[Category: Peters GH]] |
- | [[Category: Peters | + | |
- | + | ||
- | + |
Current revision
Crystal structure of PTP1B complexed with 7-(1,1-Dioxo-1H-benzo[d]isothiazol-3-yloxymethyl)-2-(oxalyl-amino)-4,7-dihydro-5H-thieno[2,3-c]pyran-3-carboxylic acid
|
Categories: Homo sapiens | Large Structures | Andersen HS | Branner S | Ge Y | Hansen TK | Holsworth DD | Iversen LF | Lau J | Moller KB | Moller NPH | Mortensen SB | Newman MJ | Olsen OH | Peters GH